The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Drug Manufacturers - Other > TAP Pharmaceutical Products Inc.

TAP Pharmaceutical Products Inc.
 PROFILE
TAP Pharmaceutical Products (formerly TAP Holdings) taps into the drug industry's hottest trends. A 50/50 joint venture between Abbott Laboratories and Japan's Takeda Chemical Industries, the firm focuses on developing and marketing drugs in the US and Canada. Its focus areas include cancer, gastroenterology, gynecology, and urology. TAP's product Lupron is used to treat prostate cancer and endometriosis. TAP also markets gastric acid inhibitor Prevacid with parent Abbott. Among its drug candidates is fast-acting (15 minutes or less) erectile dysfunction treatment Uprima. Facing questions about Uprima's efficacy and safety, TAP has withdrawn its FDA application; the drug has won approval in Europe.

 COMPETITION
AstraZeneca PLC (AZN)
PRAECIS PHARMACEUTICALS INCORPORATED (PRCS)
Pfizer Inc (PFE)

 FINANCIAL OVERVIEW
Fiscal Year-End: December
1999 Sales (mil.): 2,927.50
1-Yr. Sales Growth: 41.9%
Employees: 2,000
Revenue per employee: $1,463,750.00

 KEY PEOPLE
• H. Thomas Watkins
    CEO
• Kevin Dolan
    CFO

 CONTACT INFO
675 North Field Dr.
Lake Forest, IL 60045
US
Phone: -
Fax: 800-830-6936
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001